Testing positive for COVID-19 means acting quickly on a short checklist: contact your doctor about antiviral treatment within the first day or two, isolate from others in your household, manage your symptoms with rest and fluids, and watch for warning signs that would send you to an emergency room. The window for the most effective prescription treatment is narrow, so that call to your provider should come before almost anything else. Beyond those first steps, though, there are practical decisions about when to return to work, how to protect the people you live with, and what to expect in the weeks after you recover.
Confirm Your Result and Time It Right
If you used a rapid antigen test at home, you can generally trust a positive result. These tests are highly specific, meaning false positives are rare. A negative result is less reliable, especially in the first day or two of symptoms when viral load may not have peaked yet. A large Cochrane review found that rapid antigen tests averaged about 81% sensitivity in the first week of symptoms but dropped to roughly 54% in the second week.
Timing matters for more than just accuracy. The first week of symptoms is when your viral load is highest and, by extension, when you are most contagious and most likely to benefit from antiviral drugs. If your first test is negative but you have symptoms consistent with COVID, test again in 24 to 48 hours. Rapid tests perform best when viral shedding is at its peak, generally days two through five of symptoms.1Cochrane Database of Systematic Reviews. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection2PubMed Central. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms
One way to squeeze more sensitivity out of a home test is to swab both your nose and throat rather than just one. A study comparing swab sites found that using either site alone caught about 65% of cases confirmed by PCR, but combining both sites on a single swab pushed detection up to roughly 82%.3PubMed Central. Investigating the Sensitivity of Nasal or Throat Swabs: Combination of Both Swabs Increases the Sensitivity of SARS-CoV-2 Rapid Antigen Tests Many test kits instruct you to swab only the nose, so check your kit’s instructions and your local health authority’s guidance before modifying the procedure.
Call Your Doctor About Paxlovid Immediately
This is the single most time-sensitive action item. Nirmatrelvir/ritonavir, sold as Paxlovid, is an oral antiviral that can dramatically reduce the risk of hospitalization and death in people at higher risk of severe disease. In the original clinical trial, high-risk adults who started Paxlovid within three days of symptom onset had about an 89% lower risk of hospitalization or death compared to placebo. All 13 deaths in the trial occurred in the placebo group.4PubMed Central. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Real-world data from a large U.S. database confirmed the pattern: people treated with Paxlovid within five days of diagnosis had about 65% lower odds of hospitalization, and this held regardless of vaccination status.5PubMed Central. Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3C But the drug works better the sooner you start. A study of more than 87,000 Paxlovid users in Hong Kong found that starting within the first day or two of symptoms or diagnosis was significantly more effective than waiting even a couple of extra days.6PubMed Central. Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation
Who qualifies? Paxlovid is generally prescribed for people at higher risk for severe COVID: older adults, people with chronic conditions like diabetes, heart disease, obesity, or lung disease, and those with weakened immune systems. If you are under 50, otherwise healthy, vaccinated, and your symptoms feel like a bad cold, your doctor may decide you do not need it. The drug also interacts with a long list of other medications because its ritonavir component blocks a major liver enzyme used to metabolize many common drugs. Your provider needs to review everything you take before prescribing it.7PubMed Central. Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
What About Paxlovid Rebound?
You may have heard that some people who take Paxlovid feel better, stop the drug, and then have symptoms or a positive test flare back up a few days later. This is real, though probably less dramatic than social media makes it sound. A prospective study found that about 19% of Paxlovid-treated participants experienced symptom rebound, compared to 7% in an untreated control group. Viral rebound on testing showed a smaller gap, about 14% versus 9%.8medRxiv. The Paxlovid Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences Between Paxlovid and Untreated COVID-19 Participants
Rebound is generally mild and short-lived. If it happens to you, it does not mean the drug failed. The original benefit in preventing severe outcomes still holds. Some researchers suspect the rebound relates to the virus rebounding briefly once the drug clears your system, but the Hong Kong data noted above suggested that very early initiation might be associated with slightly higher rebound rates, though that finding was uncertain due to small numbers.6PubMed Central. Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation If you do rebound, re-isolate and treat it like a fresh infectious window until symptoms resolve and your rapid test turns negative.
Managing Symptoms at Home
Most people with COVID can recover at home. The basics are the same as for any acute respiratory infection: rest, fluids, and over-the-counter medications for fever and pain. Acetaminophen and ibuprofen are both fine to use. If you have a cough, a standard over-the-counter cough suppressant can help, and honey in warm water is a reasonable sore-throat remedy for adults.
One low-tech measure worth trying is saline nasal irrigation. A multidisciplinary review found that saline rinses reduced SARS-CoV-2 viral load in the nose and throat and appeared to hasten viral clearance, with patients reporting meaningful symptom relief.9PubMed Central. Saline nasal irrigation and gargling in COVID-19: a multidisciplinary review of effects on viral load, mucosal dynamics, and patient outcomes A randomized trial using seawater-based nasal washes found that COVID patients with severe nasal symptoms recovered their sense of smell about five days earlier and experienced shorter durations of headache, sore throat, and chest congestion compared to controls.10PubMed Central. Seawater nasal wash to reduce symptom duration and viral load in COVID-19 and upper respiratory tract infections: a randomized controlled multicenter trial A neti pot or squeeze bottle with distilled or previously boiled water and saline packets is inexpensive and widely available at pharmacies.
As for supplements, the evidence is thin. A double-blind randomized trial in India tested vitamin D and zinc supplementation in COVID patients and found no effect on how quickly symptoms resolved.11PubMed Central. Vitamin D and Zinc Supplementation to Improve Treatment Outcomes among COVID-19 Patients in India: Results from a Double-Blind Randomized Placebo-Controlled Trial If you are already deficient in vitamin D, correcting that deficiency is reasonable for general health reasons, but megadosing during an active infection is not going to speed your recovery based on current evidence.
Protecting People in Your Household
COVID-19 spreads primarily through respiratory aerosols, and households are one of the most common settings for transmission. If you share your living space with others, a few measures can meaningfully reduce the risk of passing the virus along.
Stay in a separate room with the door closed as much as possible, and use a separate bathroom if one is available. Open windows or run a portable air filter in the room where you are isolating. Ventilation is one of the most important variables: research modeling indoor transmission showed that the rate of ventilation and air filtration, along with mask use, are major determinants of how much virus accumulates in shared air.12PubMed Central. A guideline to limit indoor airborne transmission of COVID-19 If you must be in shared spaces, both you and your housemates should wear well-fitting masks. N95 or KN95 masks provide substantially better filtration than cloth or surgical masks.
Surface contamination is a less significant transmission route than airborne spread, but it is not zero. The virus can persist on common surfaces for hours, though infectiousness drops sharply within the first four hours and is largely gone within about 12 hours on most materials.13PubMed. SARS-CoV-2 Viability on 16 Common Indoor Surface Finish Materials Standard household disinfectants effectively kill the virus on surfaces.14PubMed Central. Contamination of inert surfaces by SARS-CoV-2: Persistence, stability and infectivity. A review Wiping down shared surfaces like bathroom faucets, doorknobs, and kitchen counters is a sensible precaution, though it matters less than keeping shared air clean.
When to Use a Rapid Test to Gauge Contagiousness
One practical question during isolation is when you can stop. A positive rapid antigen test is a reasonable proxy for being contagious. Research comparing rapid test results to actual viral cultures found excellent agreement between the two: when the antigen test was positive, the virus was usually still culturable, meaning you could still transmit it.15PubMed Central. The Usefulness of Antigen Testing in Predicting Contagiousness in COVID-19 The practical upshot is that serial rapid testing is a useful tool. Once you are testing negative on a rapid test and your symptoms have been improving for at least 24 hours without fever-reducing medication, you are likely safe to leave isolation. Some people clear the virus in five days; others take ten or more. The test gives you a personalized answer rather than an arbitrary calendar cutoff.
Warning Signs That Need Medical Attention
Most people recover uneventfully, but you should know the red flags. Seek emergency care if you experience difficulty breathing, persistent chest pain or pressure, confusion or inability to stay awake, or bluish lips or face. These can signal that your oxygen levels are dropping or that the infection is progressing to pneumonia.
One tricky aspect of COVID is a phenomenon called silent hypoxemia, where blood oxygen levels drop without the usual feeling of being short of breath. This is one reason clinicians recommend having a pulse oximeter at home if you are at higher risk. A reading consistently below 94% while at rest warrants a call to your doctor, and below 90% is typically an emergency. Be aware that pulse oximeters can be less accurate in people with darker skin tones, potentially underestimating the severity of the problem.16American Journal of Respiratory and Critical Care Medicine. Why COVID-19 Silent Hypoxemia Is Baffling to Physicians If your oximeter reading looks fine but you feel significantly worse, trust your body and get evaluated.
Brain Fog and Mental Health During Acute Illness
Cognitive cloudiness during and after COVID is not just “feeling sick.” Research has shown that even mild respiratory infections with SARS-CoV-2 can trigger inflammatory activity in the brain, including elevated levels of inflammatory molecules in cerebral spinal fluid and increased reactivity among microglia, the brain’s immune cells.17PubMed Central. Role of Microglia, Decreased Neurogenesis and Oligodendrocyte Depletion in Long COVID-Mediated Brain Impairments This neuroinflammation can also affect dopamine signaling, which may explain why some people feel not just foggy but unmotivated and emotionally flat during and after their illness.18PubMed Central. Long Covid brain fog: a neuroinflammation phenomenon?
If you find yourself struggling with concentration, word-finding, or short-term memory in the days and weeks after your infection, know that this is a recognized biological effect, not laziness or anxiety. For most people it clears up within a few weeks, though a minority experience it for months. Give yourself permission to slow down cognitively during recovery the same way you would rest a sprained ankle.
Returning to Exercise and Normal Activity
Jumping back into your usual workout routine too soon after COVID is a common mistake. Even a mild case puts stress on the cardiovascular and respiratory systems, and pushing hard before they have recovered can cause setbacks. Clinical guidance recommends a gradual, phased return to exercise that starts with light activity like walking and only ramps up intensity once you can tolerate each level without unusual fatigue, chest discomfort, or breathlessness.19PubMed Central. Safe Return to Exercise after COVID-19 Infection
A reasonable approach is to rest completely until your acute symptoms have resolved, then spend three to five days at very low intensity before adding any moderate effort. If you had a more severe case or experienced chest symptoms, talk to your doctor before resuming any vigorous exercise. Athletes and people with demanding physical jobs should be especially cautious, as post-viral cardiac inflammation, while uncommon, is a real risk after COVID.
Considerations for People With Weakened Immune Systems
If you are on immunosuppressive medications for an organ transplant, an autoimmune disease, or cancer treatment, COVID can behave differently for you. People with weakened immune systems are more prone to severe illness and tend to shed the virus for longer periods, sometimes weeks. Standard five-day courses of antivirals that work well for most people may not be enough to clear the infection in this group.20PubMed. Antiviral combination therapies for persistent COVID-19 in immunocompromised patients21PubMed Central. Early combined therapy for COVID-19 in immunocompromised patients: a promising approach against viral persistence and drug resistance
If this describes your situation, contact your specialist early. You may need extended antiviral courses, combination antiviral therapy, or monoclonal antibody treatment if an active product is available. Persistent infection in immunocompromised people is also a setting where drug-resistant viral variants can emerge, which is another reason for close medical follow-up rather than a watch-and-wait approach.
Lowering Your Risk of Long COVID
Long COVID, defined loosely as symptoms persisting beyond three months, remains one of the most anxiety-provoking aspects of getting infected. There is no guaranteed way to prevent it, but emerging evidence points to one surprisingly accessible intervention: metformin, a widely used and inexpensive diabetes drug.
In the COVID-OUT randomized trial, participants who took metformin starting during their acute infection had a 41% lower risk of developing long COVID over ten months of follow-up. Among those who started the drug within three days of symptom onset, the risk reduction was even larger, about 63%. A second large randomized trial, ACTIV-6, found a similar pattern, with metformin roughly halving the risk of being diagnosed with long COVID at six months.22PubMed Central. Preventing Long COVID With Metformin This is still an evolving area, and metformin for this purpose is off-label, but the signal from two independent placebo-controlled trials is stronger than almost anything else in the long-COVID prevention space. It is worth discussing with your doctor, especially if you have other risk factors.
What Happens to Your Immunity After Recovery
A COVID infection does give you meaningful immune protection against getting sick again, but it fades. A large study from Qatar found that protection from a pre-Omicron infection against reinfection peaked at about 91% around seven months, then gradually waned to roughly 70% by sixteen months and an estimated 50% by about twenty-two months.23PubMed Central. Duration of immune protection of SARS-CoV-2 natural infection against reinfection Protection against new variants is substantially lower from the start: the same study estimated that pre-Omicron infection provided only about 38% protection against Omicron reinfection, declining to near zero within about fifteen months.
A total-population study from Sweden found that natural immunity was associated with a 95% lower risk of reinfection in the first three months and 87% lower risk of hospitalization for up to twenty months, but adding vaccination on top of infection-acquired immunity made a noticeable difference. People with “hybrid immunity” from both infection and two vaccine doses had a 66% lower reinfection risk compared to natural immunity alone, and that advantage held steady for at least nine months.24The Lancet Infectious Diseases. Risk of SARS-CoV-2 reinfection and hospitalisation and the effectiveness of natural and hybrid immunity Israeli data confirmed the pattern: unvaccinated people who recovered from COVID saw their reinfection rate triple between six months and one year post-infection, while those who got even a single vaccine dose after infection kept their rates much lower for longer.25PubMed Central. Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
The practical takeaway: having just recovered from COVID does not make you immune for life, and you should still plan on getting an updated vaccine booster once you have recovered. Most guidelines suggest waiting at least a couple of months after infection before getting vaccinated, both because your natural immunity provides good short-term protection and because spacing out the immune stimulus tends to produce a stronger response. If you are trying to time your next booster strategically, modeling work suggests that in the Northern Hemisphere, getting boosted in September or October tends to provide the best protection heading into the winter surge season.26Clinical Infectious Diseases. Optimal Annual COVID-19 Vaccine Boosting Dates Following Previous Booster Vaccination or Breakthrough Infection
The Practical Side of Staying Home
One of the hardest parts of a COVID diagnosis has nothing to do with biology: figuring out whether you can afford to stay home from work. Research during the pandemic made clear that paid sick leave is not just a personal benefit but a public health tool. A study of a large restaurant chain found that when the company expanded paid sick leave, the share of employees working while sick dropped measurably.27PubMed Central. Olive Garden’s Expansion Of Paid Sick Leave During COVID-19 Reduced The Share Of Employees Working While Sick At the state level, temporary federal paid sick leave mandates during 2020 led to increased self-quarantining and a subsequent decline in confirmed COVID cases.28PubMed Central. Does paid sick leave encourage staying at home? Evidence from the United States during a pandemic
The federal emergency mandate has expired, and paid sick leave policies now vary widely by state, city, and employer. If you do not have paid sick leave and cannot work remotely, the tension between doing the right thing epidemiologically and paying your bills is real and unresolved by science alone. What the evidence does tell you is that staying home during the first five to seven days of symptoms, when your viral load and contagiousness are highest, is when isolation matters most. If you must return to shared spaces before testing negative, wearing a well-fitting mask and keeping distance from others are the best available compromises.